311 related articles for article (PubMed ID: 17169759)
1. Viral gene therapy.
Mancheño-Corvo P; Martín-Duque P
Clin Transl Oncol; 2006 Dec; 8(12):858-67. PubMed ID: 17169759
[TBL] [Abstract][Full Text] [Related]
2. Viral vectors for gene therapy.
Robbins PD; Ghivizzani SC
Pharmacol Ther; 1998 Oct; 80(1):35-47. PubMed ID: 9804053
[TBL] [Abstract][Full Text] [Related]
3. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
Walther W; Stein U
Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
[TBL] [Abstract][Full Text] [Related]
4. Viral-mediated gene transfer for cancer treatment.
Wilson DR
Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258
[TBL] [Abstract][Full Text] [Related]
5. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
Dalba C; Klatzmann D; Logg CR; Kasahara N
Curr Gene Ther; 2005 Dec; 5(6):655-67. PubMed ID: 16457654
[TBL] [Abstract][Full Text] [Related]
6. Vector-mediated cancer gene therapy: an overview.
Seth P
Cancer Biol Ther; 2005 May; 4(5):512-7. PubMed ID: 15908802
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic virus therapy using genetically engineered herpes simplex viruses.
Todo T
Front Biosci; 2008 Jan; 13():2060-4. PubMed ID: 17981691
[TBL] [Abstract][Full Text] [Related]
8. Invasive drug delivery.
Blömer U; Ganser A; Scherr M
Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831
[TBL] [Abstract][Full Text] [Related]
9. Cancer gene therapy using adeno-associated virus vectors.
Park K; Kim WJ; Cho YH; Lee YI; Lee H; Jeong S; Cho ES; Chang SI; Moon SK; Kang BS; Kim YJ; Cho SH
Front Biosci; 2008 Jan; 13():2653-9. PubMed ID: 17981740
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus 1 (HSV-1) for cancer treatment.
Shen Y; Nemunaitis J
Cancer Gene Ther; 2006 Nov; 13(11):975-92. PubMed ID: 16604059
[TBL] [Abstract][Full Text] [Related]
11. Advance in herpes simplex viruses for cancer therapy.
Liu S; Dai M; You L; Zhao Y
Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
[TBL] [Abstract][Full Text] [Related]
12. Strategies for retargeted gene delivery using vectors derived from lentiviruses.
Bartosch B; Cosset FL
Curr Gene Ther; 2004 Dec; 4(4):427-43. PubMed ID: 15578992
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral vectors for prodrug activation-based gene therapy for cancer.
Doloff JC; Waxman DJ
Anticancer Agents Med Chem; 2014 Jan; 14(1):115-26. PubMed ID: 23869779
[TBL] [Abstract][Full Text] [Related]
14. Development of herpesvirus-based episomally maintained gene delivery vectors.
Calderwood MA; White RE; Whitehouse A
Expert Opin Biol Ther; 2004 Apr; 4(4):493-505. PubMed ID: 15102599
[TBL] [Abstract][Full Text] [Related]
15. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
16. [Gene therapy: new developments].
Mohr L; Geissler M
Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
[TBL] [Abstract][Full Text] [Related]
17. Pseudotyped Viruses for Retroviruses.
Solomon M; Liang C
Adv Exp Med Biol; 2023; 1407():61-84. PubMed ID: 36920692
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus as an integrating vector.
Mitani K; Kubo S
Curr Gene Ther; 2002 May; 2(2):135-44. PubMed ID: 12109211
[TBL] [Abstract][Full Text] [Related]
19. Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications.
Advani SJ; Weichselbaum RR; Whitley RJ; Roizman B
Clin Microbiol Infect; 2002 Sep; 8(9):551-63. PubMed ID: 12427216
[TBL] [Abstract][Full Text] [Related]
20. Recent Patents in Oncolytic Virotherapy.
Ahmad T; Venkataraman S; AbouHaidar M; Hefferon KL
Recent Pat Biotechnol; 2016; 9(2):79-85. PubMed ID: 26961667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
